We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FEBO:NASDAQFenbo Holdings Limited Analysis

Data as of 2026-05-23 - not real-time

$1.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Fenbo Holdings is trading near its 20‑day support level with the 20‑day moving average sitting below the 50‑day average, signaling a short‑term downtrend. The RSI hovers just under 40, suggesting weakening momentum, while the MACD line remains beneath its signal, confirming bearish pressure. Volatility is extremely high at roughly 62% over the past month, and the stock has experienced a historic drawdown exceeding 50%, underscoring the risk of further price swings. On the fundamentals side, revenue has collapsed by more than a third year‑over‑year and margins are deeply negative, leaving the company with a negative EPS and a trailing PE of zero. Despite the earnings pain, the balance sheet shows modest cash against a manageable debt load, and free cash flow is positive, offering a thin cushion. The discounted cash‑flow model values the business at over $6 per share, far above the current $1 price, indicating a sizable valuation gap. However, the lack of any dividend and a zero forward EPS diminish the appeal for income‑focused investors. The company operates globally across Europe, North America and Asia, exposing it to multiple regulatory regimes and currency environments. Liquidity is thin, with daily volumes well under the 10‑day average, making large trades difficult without impact. Overall, the stock sits at the intersection of deep valuation discount and pronounced downside risk, requiring a nuanced timing approach.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD histogram
  • RSI below 40 indicating weak momentum
  • Price testing near 20‑day support

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Substantial DCF upside potential
  • Positive free cash flow despite earnings losses
  • High volatility that could produce swing opportunities

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • DCF fair value suggests >500% upside
  • Low beta implying limited market sensitivity
  • Potential turnaround if revenue growth stabilizes

Key Metrics & Analysis

Financial Health

Revenue Growth-35.90%
Profit Margin-12.52%
ROE-26.23%
ROA-8.10%
Debt/Equity41.84
P/B Ratio2.4
Op. Cash Flow$1.6M
Free Cash Flow$5.0M
Industry P/E39.5

Technical Analysis

TrendNeutral
RSI39.0
Support$0.96
Resistance$1.24
MA 20$1.10
MA 50$1.15
MA 200$0.97
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$6.29
GradeUndervalued
TypeValue

Risk Assessment

Beta0.08
Volatility61.92%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.